According to SEC filings for the period ending December 2025, Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) is held by 151 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 31 Dec, 2025 | 7,692,298 | 0 | 0.00% | $120,615,233.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 4,622,151 | 4,622,151 | 0.00% | $72,475,328.00 |
| Versant Venture Management, LLC | 31 Dec, 2025 | 4,382,687 | -1,270,235 | -22.47% | $68,720,532.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 4,345,736 | -570,359 | -11.60% | $68,141,140.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,181,161 | 366,028 | 9.59% | $65,560,605.00 |
| BVF INC/IL | 31 Dec, 2025 | 3,835,886 | -1,824,246 | -32.23% | $60,146,692.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,360,000 | 0 | 0.00% | $52,684,800.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,246,500 | 257,547 | 8.62% | $50,905,120.00 |
| STATE STREET CORP | 31 Dec, 2025 | 2,107,480 | 1,260,707 | 148.88% | $33,045,286.00 |
| Aisling Capital Management LP | 31 Dec, 2025 | 1,472,331 | 0 | 0.00% | $23,086,150.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Dec, 2025 | 1,329,619 | 736,225 | 124.07% | $20,848,426.00 |
| FMR LLC | 31 Dec, 2025 | 1,300,096 | -1,512,155 | -53.77% | $20,385,505.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,204,844 | 53,278 | 4.63% | $18,896,352.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 1,173,376 | 1,173,376 | 0.00% | $18,398,536.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,029,066 | 334,124 | 48.08% | $16,135,755.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 948,316 | 948,316 | 0.00% | $14,869,595.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 805,530 | 160,334 | 24.85% | $12,630,711.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 785,057 | 67,795 | 9.45% | $12,309,694.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 775,000 | -25,000 | -3.13% | $12,152,000.00 |
| Alphabet Inc. | 31 Dec, 2025 | 744,948 | -719,067 | -49.12% | $11,680,785.00 |